Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform
Expanded IP Portfolio Enhances Data Harmonization and Predictive Analytics Capabilities for High-Growth Biomedical Markets
LOS ANGELES, June 03, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a clinical-stage precision medicine company, today announced that its subsidiary BioSymetrics has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a new patent application titled 'Methods, Systems, and Frameworks for Unbiased Data in Drug Discovery Predictions' (Application No. 18/058,752).
This patent strengthens Renovaro's AI and machine learning intellectual property portfolio by protecting novel methods for integrating and harmonizing diverse biomedical data sources—such as genomics, electronic health records, imaging, and clinical trial data—into a standardized framework for predictive modeling.
'This patent is a strategic milestone for Renovaro,' said David Weinstein, CEO of Renovaro. 'Together with our previously granted patent, it forms the technological foundation of a scalable, end-to-end platform for AI-powered drug discovery and diagnostics and strengthens our position in the fast-growing market for data-driven therapeutics and clinical insights.'
Key Drivers for Renovaro:
Expands Foundational IP: Builds on core patent (US 11,379,757), granted in July 2022, which protects machine learning pipeline optimization through advanced feature selection and model tuning.
Addresses Real-World Challenges: Tackles integration of siloed and heterogeneous data—an unmet need in pharmaceutical R&D and clinical practice.
Enhances Commercial Potential: Enables scalable, distributed computing for biomedical analytics across use cases in rare disease, clinical trials, and personalized medicine.
Supports Revenue Growth Strategy: Protects Renovaro's differentiated technology approach, critical for commercial partnerships, licensing opportunities, and platform deployment in life sciences and healthcare.
The new patent introduces methods that operate across distributed and parallel computing environments, allowing for real-time, reproducible predictive analytics at scale. This infrastructure is vital as the biopharma industry increases reliance on AI to improve efficiency, reduce costs, and accelerate time-to-market for new therapies.
This patent allowance reinforces Renovaro's commitment to building category-defining technology platforms that drive value for patients, partners, and shareholders alike.
About Renovaro Inc.
Renovaro https://renovarogroup.com/ aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. Renovaro Inc. includes RenovaroBio with its advanced cell-gene immunotherapy company and RenovaroCube that is leveraging AI for multi-omic diagnostics and drug development, and BioSymetrics which specializes in contingent AI for precision neurology. For more information, visit www.renovarogroup.com.
Forward-Looking Statements
This release contains forward-looking statements, including those relating to the pending litigation and the proposed merger. These statements involve risks and uncertainties and are subject to change based on future developments. Renovaro undertakes no obligation to update any forward-looking statements except as required by law.
Investor Relations
Chris Tyson
Executive Vice President
MZ Group - MZ North America
949-491-8235
RENB@mzgroup.us
www.mzgroup.us
For media inquiries, please contact:
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
38 minutes ago
- Globe and Mail
Hisense Unveils M2 Pro, Its Smallest, Lightest, Most Portable 4K Laser Mini Projector Ever
QINGDAO, China , /CNW/ -- Hisense, a leading brand in global consumer electronics and home appliances, announces the newest addition to its Laser TV lineup, the M2 Pro Laser Mini Projector. This powerhouse of a device pushes the boundaries of compact projection, delivering an immersive 4K cinematic experience anywhere, powered by innovative technologies never before seen in such a portable form factor. The Hisense M2 Pro Laser Mini Projector represents a paradigm shift in portable home cinema. By successfully miniaturizing and perfecting advanced laser and AI technologies, Hisense has created its smallest, lightest, and most portable laser projector to date, offering a powerful, versatile, and incredibly user-friendly device that delivers a premium, large-screen experience wherever life takes you. Next Gen Technology Miniaturized At the heart of the M2 Pro is the advanced AI 4K Clarity technology, a sophisticated suite of algorithms working in harmony to deliver pristine images. This includes a powerful AI 4K Upscaler that intelligently transforms lower-resolution content into stunning 4K detail, an AI Noise Reduction feature ensuring a clean and clear picture, and an AI HDR Upscaler that meticulously optimizes contrast and highlights for a more dynamic viewing experience. With 2.07 million micromirrors powered by a precision DLP system, the M2 Pro projects detailed 4K visuals up to an expansive 200 inches, ensuring crystal-clear precision down to every pixel. Hisense's Pure Triple Color Laser technology, a hallmark of Hisense's premium Laser TV products, uses discrete red, green, and blue lasers to produce an exceptionally wide color gamut, rendering images with unparalleled vibrancy and lifelike accuracy. The successful miniaturization of this core laser engine is the key to the M2 Pro's unprecedented compact size and light weight, making true 4K laser projection genuinely portable for the first time in Hisense's history. Advanced Imaging and Seamless Adaptability A major technological leap for portable projection, the M2 Pro features Optical Zoom with a 1.0–1.3 throw ratio. This engineering marvel allows users to precisely adjust the image size and distance while maintaining full 4K sharpness—a crucial advantage that sets it apart from digital-only zoom solutions which often degrade image quality. This optical innovation, combined with the impressive 65-inch to 200-inch screen adaptability, ensures a seamless and high-quality viewing experience in virtually any environment, whether indoors or outdoors. Effortless Setup and Immersive Audio Ease of use is paramount to the M2 Pro's design, powered by cutting-edge automation. Hisense has integrated advanced features to make setup effortless: seamless auto keystone correction and auto focus ensure the image is always sharp and perfectly aligned, eliminating manual tweaking. Furthermore, the intelligent 7-tailored wall color adaptation automatically adjusts projected colors to compensate for the hue of the projection surface, guaranteeing vivid, accurate colors even when projecting directly onto a non-white wall – a groundbreaking feature for truly adaptable projection. Beyond visuals, the M2 Pro delivers an immersive audio experience with built-in Dolby Audio & DTS Virtual:X technology, providing rich, spatial sound without the need for external speakers. Powered by the intuitive and popular VIDAA Smart OS, users can directly stream from top platforms including Netflix, YouTube, and Disney+, all easily navigated with a convenient voice remote. The inclusion of Dolby Vision and multiple HDR formats further ensures nuanced detail from shadows to highlights, perfect for both movies and gaming. The Hisense M2 Pro stands as a testament to Hisense's relentless pursuit of innovation, embodying the pinnacle of portability without compromising on a breathtaking big-screen experience. This revolutionary projector ushers in a new era for home cinema by enabling expansive 4K visuals from a device engineered for ultimate flexibility and ease of use. The Hisense M2 Pro Laser Mini Projector will be coming soon to key markets worldwide, including the United States , Germany , Australia , among others. Release dates, price, and availability will be determined by local markets in the weeks to come so please stay tuned. About Hisense Hisense, founded in 1969, is a globally recognized leader in home appliances and consumer electronics with operations in over 160 countries, specializing in delivering high-quality multimedia products, home appliances, and intelligent IT solutions. According to Omdia, Hisense ranks No. 2 worldwide in total TV shipments (2022-2024) and No. 1 globally in the 100-inch and over TV segment (2023-2025 Q1). As the first official partner of the FIFA Club World Cup 2025™, Hisense is committed to global sports partnerships as a way to connect with audiences worldwide.
CBC
39 minutes ago
- CBC
Israel recovers bodies of Canadian Israeli Judih Weinstein-Haggai and husband held by Hamas
Israel's military recovered the bodies of two hostages, Canadian Israeli Judih Weinstein-Haggai and her husband, Israeli American Gadi Haggai, who were held by Hamas, Prime Minister Benjamin Netanyahu said on Thursday. The Israeli army said in a statement that the bodies of the husband and wife were recovered in a special operation from Khan Younis area in the Gaza Strip. "Together with all the citizens of Israel, my wife and I extend our heartfelt condolences to the dear families. Our hearts ache for the most terrible loss. May their memory be blessed," Netanyahu said in a statement. Kibbutz Nir Oz announced the deaths of Weinstein-Haggai, 70, and Haggai, 72, both of whom had Israeli and U.S. citizenship, in December 2023. The Israeli military said they were killed in the Oct. 7, 2023 attack and taken into Gaza by the Mujahideen Brigades, the small armed group that it said had also abducted and killed Shiri Bibas and her two small children. Weinstein-Haggai grew up in Canada and held Canadian and U.S. citizenship. She was born in New York state but moved to Toronto at the age of three, and then moved to Israel 20 years later to live with Haggai. She was a mother of four and a grandmother of seven. Following the recovery of two bodies, 56 hostages are still held by Hamas, with fewer than half believed to be alive, according to Israeli estimates. Israel launched its military campaign in Gaza following the Oct. 7 assault in which Hamas-led gunmen killed 1,200 people and took 251 hostages, by Israeli tallies. In the subsequent fighting, more than 54,000 Palestinians have been killed, local health authorities say.
Globe and Mail
an hour ago
- Globe and Mail
Trump doubles down on steel, aluminum tariffs
On Tuesday, U.S. President Donald Trump signed a new executive order that raised tariffs on steel and aluminum from 25 per cent to 50 per cent. One Canadian steel producer said this means that their American business is now 'unviable'. Jason Kirby is a staff reporter for The Globe's Report on Business section. He explains why these higher steel and aluminum tariffs could mean higher prices on nearly everything, and what may have contributed to Trump's escalation. Questions? Comments? Ideas? Email us at thedecibel@
